| ARTIVION INC. DL-,01 |
| USA |
| Gesundheit |
| US2289031005 / 900006 |
| CYL (Frankfurt) / AORT (NYSE) |
| FRA:CYL, ETR:CYL, CYL:GR, NYSE:AORT |
| - |
| https://artivion.com/ |
|
Artivion Inc. is a medical device company focused on providing innovative technology solutions aimed at improving patient outcomes. Its primary function is to develop, manufacture, and sell devices as..
>Volltext.. |
| 1520.67 Mio. EUR |
| 1685.66 Mio. EUR |
| 374.85 Mio. EUR |
| 53.09 Mio. EUR |
| 8.29 Mio. EUR |
| 0.18 EUR |
| 219.57 Mio. EUR |
| 55.13 Mio. EUR |
| 33.87 Mio. EUR |
| 0.64 |
| 0.12% |
| - |
| - |
| - |
| - |
| 09.12.15 - 0.02574€ 09.09.15 - 0.02574€ >weitere anzeigen... |
| ARTIVION |
| 26.02.26 |
|